Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...
In Friday's hearing, which lasted 10 hours, U.S. Bankruptcy Judge Christopher Lopez heard closing arguments in Johnson & ...
Johnson is appearing before the Committee on Oversight and Government Reform to defend the city’s law that, in part, ...
JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.
BofA raised the firm’s price target on Johnson & Johnson (JNJ) to $171 from $159 and keeps a Neutral rating on the shares. For the last ...
House Speaker Mike Johnson’s chief of staff Hayden Haynes was arrested shortly after President Donald Trump’s speech to ...
Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...
We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...